SNPgen: Phenotype-Supervised Genotype Representation and Synthetic Data Generation via Latent Diffusion

Individual-level genotype data underpin genetic discovery, disease-risk modeling, and therapeutic development, yet many critical settings remain data-limited, including underrepresented ancestries, rare or imbalanced disease cohorts, and restricted-access biobanks. Conditional synthetic genome generation would support privacy-aware benchmarking, simulation, and data augmentation, but requires learning an ultra-high-dimensional discrete distribution over hundreds of thousands to tens of millions of correlated single-nucleotide polymorphisms (SNPs), or sites of DNA variation. We introduce HELICS: High-fidelity gEneration via Latent Interpolant Conditional Synthesis, a phasing-free latent flow matching framework for genome-wide SNP-level generation from biobank-scale genotype data. HELICS tokenizes chromosomes with convolutional autoencoders, reducing >600K SNPs to 4,096 continuous latent tokens, and trains a transformer parameterized conditional flow matching model over the concatenated multi-chromosome latent representation. Trained on over 417K genomes in the UK Biobank, HELICS generates genome-wide common-variant synthetic cohorts without haplotype phasing and achieves stronger fidelity to real genotypes than existing haplotype-based simulators, including high allele-frequency agreement in external evaluation and superior preservation of local and long-range SNP correlation structure. Conditioning on ancestry and genetic liability summaries enables targeted generation across genetic risk profiles; in perturbation analyses, by increasing the conditioned disease trait liability, HELICS induces SNP-level dosage changes in generated genomes that are highly correlated with published association weights. HELICS provides a scalable generative modeling framework for SNP-level genome data and a path toward conditional synthetic cohorts for data-limited genetic studies.

The development of medical AI is constrained by limited access to high-quality clinical data due to institutional silos and strict privacy regulations such as HIPAA and GDPR. Synthetic data generation offers a potential solution, but existing methods lack principled mechanisms to explicitly manage the privacy-utility trade-off, often degrading clinically meaningful patterns or risking patient re-identification. We present PSyGenTAB, a privacy-preserving generative framework that formulates synthetic healthcare data generation as a constrained optimization problem solved using the Augmented Lagrangian Method. By embedding configurable privacy constraints directly into model training, PSyGenTAB enforces minimum privacy thresholds while maximizing clinical data utility. Across multiple clinically motivated benchmarks, PSyGenTAB preserves inter-feature clinical relationships and minority-class diagnostic patterns essential for reliable health AI. Downstream evaluation using Train-on-Synthetic, Test-on-Real and Train-on-Real, Test-on-Synthetic protocols shows that models trained on synthetic data achieve performance comparable to those trained on real patient records. Privacy auditing further demonstrates reduced exact record reproduction and strong resilience to membership inference attacks. These results establish PSyGenTAB as a principled framework for balancing privacy protection and clinical utility in synthetic healthcare data, supporting secure cross-institutional AI development.

Synthetic healthcare data are widely proposed as privacy-preserving substitutes for real patient data, yet their evaluation remains dominated by statistical similarity and predictive performance that do not reflect clinical validity. We introduce a multi-dimensional evaluation framework grounded in epidemiology, assessing descriptive fidelity, clinical utility, and structural validity, corresponding to descriptive, predictive, and causal questions. We evaluate four representative generative paradigms - GAN-based, VAE-boosted, diffusion-based, and masked modelling - using PRIME-CVD, a 50,000-person cohort with known ground-truth structure. While all models reproduce marginal distributions, none simultaneously preserve subgroup structure, effect estimates, and dependency structure. Notably, models with strong distributional fidelity can exhibit poor calibration and distorted relationships, leading to unreliable inference. These results show that current evaluation practices can overestimate synthetic data quality and motivate domain-informed assessment based on the ability to support valid clinical and scientific conclusions.